Genetic Variants of Adrenoceptors

Overview

Journal Handb Exp Pharmacol

Specialty Pharmacology

Date 2023 Aug 14

PMID 37578621

Authors

Andrea Ahles

Stefan Engelhardt

Affiliations

Soon will be listed here.

Abstract

Adrenoceptors are class A G-protein-coupled receptors grouped into three families (α-, α-, and β-adrenoceptors), each one including three members. All nine corresponding adrenoceptor genes display genetic variation in their coding and adjacent non-coding genomic region. Coding variants, i.e., nucleotide exchanges within the transcribed and translated receptor sequence, may result in a difference in amino acid sequence thus altering receptor function and signaling. Such variants have been intensely studied in vitro in overexpression systems and addressed in candidate-gene studies for distinct clinical parameters. In recent years, large cohorts were analyzed in genome-wide association studies (GWAS), where variants are detected as significant in context with specific traits. These studies identified two of the in-depth characterized 18 coding variants in adrenoceptors as repeatedly statistically significant genetic risk factors - p.Arg389Gly in the β- and p.Thr164Ile in the β-adrenoceptor, along with 56 variants in the non-coding regions adjacent to the adrenoceptor gene loci, the functional role of which is largely unknown at present. This chapter summarizes current knowledge on the two coding variants in adrenoceptors that have been consistently validated in GWAS and provides a prospective overview on the numerous non-coding variants more recently attributed to adrenoceptor gene loci.

References

Abecasis G, Auton A, Brooks L, DePristo M, Durbin R, Handsaker R . An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491(7422):56-65. PMC: 3498066. DOI: 10.1038/nature11632. View

Ahles A, Engelhardt S . Polymorphic variants of adrenoceptors: pharmacology, physiology, and role in disease. Pharmacol Rev. 2014; 66(3):598-637. DOI: 10.1124/pr.113.008219. View

Ahles A, Rodewald F, Rochais F, Bunemann M, Engelhardt S . Interhelical interaction and receptor phosphorylation regulate the activation kinetics of different human β1-adrenoceptor variants. J Biol Chem. 2014; 290(3):1760-9. PMC: 4340418. DOI: 10.1074/jbc.M114.607333. View

Akinaga J, Garcia-Sainz J, Pupo A . Updates in the function and regulation of α -adrenoceptors. Br J Pharmacol. 2019; 176(14):2343-2357. PMC: 6592863. DOI: 10.1111/bph.14617. View

Aleong R, Sauer W, Davis G, Murphy G, Port J, Anand I . Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism. JACC Heart Fail. 2013; 1(4):338-344. PMC: 3804380. DOI: 10.1016/j.jchf.2013.04.002. View

Astle W, Elding H, Jiang T, Allen D, Ruklisa D, Mann A . The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell. 2016; 167(5):1415-1429.e19. PMC: 5300907. DOI: 10.1016/j.cell.2016.10.042. View

Barbato E, Penicka M, Delrue L, Van Durme F, De Bruyne B, Goethals M . Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy. Heart. 2007; 93(7):856-61. PMC: 1994438. DOI: 10.1136/hrt.2006.091959. View

Boeckel J, Perret M, Glaser S, Seeger T, Heumuller A, Chen W . Identification and regulation of the long non-coding RNA Heat2 in heart failure. J Mol Cell Cardiol. 2018; 126:13-22. DOI: 10.1016/j.yjmcc.2018.11.004. View

Bruck H, Leineweber K, Park J, Weber M, Heusch G, Philipp T . Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo. Clin Pharmacol Ther. 2005; 78(3):232-8. DOI: 10.1016/j.clpt.2005.06.002. View

10.

Buniello A, MacArthur J, Cerezo M, Harris L, Hayhurst J, Malangone C . The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2018; 47(D1):D1005-D1012. PMC: 6323933. DOI: 10.1093/nar/gky1120. View

11.

Buscher R, Eilmes K, Grasemann H, Torres B, Knauer N, Sroka K . beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics. 2002; 12(5):347-53. DOI: 10.1097/00008571-200207000-00002. View

12.

Chen M, Yanek L, Backman J, Eicher J, Huffman J, Ben-Shlomo Y . Exome-chip meta-analysis identifies association between variation in ANKRD26 and platelet aggregation. Platelets. 2017; 30(2):164-173. PMC: 6214797. DOI: 10.1080/09537104.2017.1384538. View

13.

Dishy V, Landau R, Sofowora G, Xie H, Smiley R, Kim R . Beta2-adrenoceptor Thr164Ile polymorphism is associated with markedly decreased vasodilator and increased vasoconstrictor sensitivity in vivo. Pharmacogenetics. 2004; 14(8):517-22. DOI: 10.1097/01.fpc.0000114763.78957.ec. View

14.

Dorn 2nd G . Adrenergic signaling polymorphisms and their impact on cardiovascular disease. Physiol Rev. 2010; 90(3):1013-62. DOI: 10.1152/physrev.00001.2010. View

15.

Ehret G, Ferreira T, Chasman D, Jackson A, Schmidt E, Johnson T . The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat Genet. 2016; 48(10):1171-1184. PMC: 5042863. DOI: 10.1038/ng.3667. View

16.

Fagerholm V, Haaparanta M, Scheinin M . α2-adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol. 2011; 108(6):365-70. DOI: 10.1111/j.1742-7843.2011.00699.x. View

17.

Giovannitti Jr J, Thoms S, Crawford J . Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth Prog. 2015; 62(1):31-9. PMC: 4389556. DOI: 10.2344/0003-3006-62.1.31. View

18.

Giri A, Hellwege J, Keaton J, Park J, Qiu C, Warren H . Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet. 2018; 51(1):51-62. PMC: 6365102. DOI: 10.1038/s41588-018-0303-9. View

19.

Gjesing A, Andersen G, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T . Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Diabet Med. 2007; 24(4):392-7. DOI: 10.1111/j.1464-5491.2006.02031.x. View

20.

Green S, Cole G, Jacinto M, Innis M, Liggett S . A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem. 1993; 268(31):23116-21. View